Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of two doses of ursodeoxycholic acid for prevention of gallstone formation
IRCT20240310061234N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ursodeoxycholic acid in cholelithiasis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on IRCT20240310061234N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240310061234N1.